Advertisement

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay

Eli Muchtar, Shaji K. Kumar, Morie A. Gertz, Martha Grogan, Omar F. AbouEzzeddine, Allan S. Jaffe and Angela Dispenzieri

Article Information

PubMed 

Print ISSN 
Online ISSN 

Article Versions


Contributors 
  • Eli Muchtar, 1 Division of Hematology, Mayo Clinic, Rochester, MN, United States;
  • Shaji K. Kumar, 1 Division of Hematology, Mayo Clinic, Rochester, MN, United States;
  • Morie A. Gertz, 1 Division of Hematology, Mayo Clinic, Rochester, MN, United States;
  • Martha Grogan, 2 Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States;
  • Omar F. AbouEzzeddine, 2 Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, United States;
  • Allan S. Jaffe, 3 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States
  • Angela Dispenzieri, 1 Division of Hematology, Mayo Clinic, Rochester, MN, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output